Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hydroxyurea in the treatment of Churg-Strauss syndrome

Similar presentations


Presentation on theme: "Hydroxyurea in the treatment of Churg-Strauss syndrome"— Presentation transcript:

1 Hydroxyurea in the treatment of Churg-Strauss syndrome
Rachel U. Lee, MD, Donald D. Stevenson, MD  Journal of Allergy and Clinical Immunology  Volume 124, Issue 5, Pages (November 2009) DOI: /j.jaci Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Quantification of proteins of interest. Figures represent average spectral count values for patients between groups. Significant differences between 2 groups using the Benjamini-Hochberg false discovery rate procedure with false discovery rate=0.05 within each protein indicated by bracket endpoints over those columns. See Methods for statistical analysis details. A, e-fabp. B, α-Enolase. C, Triosephosphate isomerase. D, Serpin B3. E, Keratin 1 type II cytoskeletal 1. F, Dermcidin. Avg, Average; nonles., nonlesional. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Hydroxyurea in the treatment of Churg-Strauss syndrome"

Similar presentations


Ads by Google